Cargando…
Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease
The hypoalbuminuric effect of sulodexide (SDX) on diabetic kidney disease (DKD) was suggested by some clinical trials but was denied by the Collaborative Study Group. In this study, the diabetic rats were treated with SDX either from week 0 to 24 or from week 13 to 24. We found that 24-week treatmen...
Autores principales: | Liu, Yu Ning, Zhou, Jingwei, Li, Tingting, Wu, Jing, Xie, Shu Hua, Liu, Hua-feng, Liu, Zhangsuo, Park, Tae Sun, Wang, Yaoxian, Liu, Wei Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591972/ https://www.ncbi.nlm.nih.gov/pubmed/28929120 http://dx.doi.org/10.1155/2017/4989847 |
Ejemplares similares
-
Klotho is regulated by transcription factor Sp1 in renal tubular epithelial cells
por: Li, Yan, et al.
Publicado: (2020) -
Lysine Acetylation in the Proteome of Renal Tubular Epithelial Cells in Diabetic Nephropathy
por: Wan, Jiayi, et al.
Publicado: (2021) -
Sulodexide in the Treatment of Early Stages of COVID-19
por: Gonzalez-Ochoa, Alejandro, et al.
Publicado: (2021) -
Protective Role of Sulodexide on Renal Injury Induced by Limb Ischemia-Reperfusion
por: Yuan, Tao, et al.
Publicado: (2021) -
The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)